Principalmed 1L, UAB - financials and debts

Company age: 24 y. 0 mo.

Update

Principalmed 1L - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 881,416 331,929 370,324 490,851 450,710 738,242 531,281 555,826
Profit before tax 88,539 -45,494 125,536 32,449 64,224 54,449 -4,371 91,235
Net profit 71,380 -45,494 109,524 27,050 54,079 38,723 -5,011 73,080
Equity 245,808 160,314 134,838 161,888 215,967 54,690 49,679 223,583
Liabilities 164,678 77,626 298,996 281,150 244,173 306,661 269,930 188,868
Non-current assets 79,323 52,940 39,642 34,003 24,827 20,045 12,451 12,342
Current assets 329,623 183,678 393,548 407,819 434,522 354,514 306,149 399,691
Total assets 408,946 236,618 433,190 441,822 459,349 374,559 318,600 412,033
Taxes paid
STI taxes - - - - - 37,705 45,520 33,840
Social insurance contributions - - - - - 16,868 18,027 13,690
Financial indicators
Revenue change y/y +107.7% -62.3% +11.6% +32.5% -8.2% +63.8% -28.0% +4.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 17.5% -19.2% 25.3% 6.1% 11.8% 10.3% -1.6% 17.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 29.0% -28.4% 81.2% 16.7% 25.0% 70.8% -10.1% 32.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 8.1% -13.7% 29.6% 5.5% 12.0% 5.2% -0.9% 13.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 10.0% -13.7% 33.9% 6.6% 14.2% 7.4% -0.8% 16.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.7 0.5 2.2 1.7 1.1 5.6 5.4 0.8
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 93,601 39,050 49,377 79,597 75,118 134,226 106,256 111,165

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Principalmed 1L - Social security debts

From To Debt, €
2022-06-16 2022-06-19 0.01

Principalmed 1L - VMI tax arrears

From To Overdue, €
2026-06-28 2026-07-07 6.29
2025-09-03 2025-09-03 0.0
2025-09-02 2025-09-02 0.0
2025-09-01 2025-09-01 0.0
2025-08-31 2025-08-31 0.0
2025-08-29 2025-08-30 0.0
2025-08-28 2025-08-28 0.0
2025-08-27 2025-08-27 0.0
2025-08-25 2025-08-26 0.0
2025-08-24 2025-08-24 0.0
2025-08-22 2025-08-23 0.0
2025-08-21 2025-08-21 0.0
2025-08-19 2025-08-20 0.0
2025-08-18 2025-08-18 0.0
2025-08-17 2025-08-17 0.0
2025-08-15 2025-08-16 0.0
2025-08-14 2025-08-14 0.0
2025-08-12 2025-08-13 0.0
2025-08-11 2025-08-11 0.0
2025-08-10 2025-08-10 0.0
2025-08-08 2025-08-09 0.0
2025-08-07 2025-08-07 0.0
2025-08-06 2025-08-06 0.0
2025-08-05 2025-08-05 0.0
2025-08-04 2025-08-04 0.0
2025-08-03 2025-08-03 0.0
2025-08-01 2025-08-02 0.0
2025-07-30 2025-07-31 0.0
2025-07-29 2025-07-29 0.0
2025-07-28 2025-07-28 0.0
2025-07-27 2025-07-27 0.0
2025-07-25 2025-07-26 0.0
2025-07-24 2025-07-24 0.0
2025-07-23 2025-07-23 0.0
2025-07-22 2025-07-22 0.0
2025-07-21 2025-07-21 0.0
2025-07-20 2025-07-20 0.0
2025-07-18 2025-07-19 0.0
2025-07-17 2025-07-17 0.0
2025-07-16 2025-07-16 0.0
2025-07-14 2025-07-15 0.0
2025-07-13 2025-07-13 0.0
2025-07-11 2025-07-12 0.0
2025-07-10 2025-07-10 0.0
2025-07-09 2025-07-09 0.0
2025-07-08 2025-07-08 0.0
2025-07-07 2025-07-07 0.0
2025-07-06 2025-07-06 0.0
2025-07-04 2025-07-05 0.0
2025-07-03 2025-07-03 0.0
2025-07-02 2025-07-02 0.0
2025-07-01 2025-07-01 0.0
2025-06-30 2025-06-30 0.0
2025-06-27 2025-06-29 0.0
2025-06-26 2025-06-26 0.0
2025-06-25 2025-06-25 0.0
2025-06-24 2025-06-24 0.0
2025-06-23 2025-06-23 0.0
2025-06-22 2025-06-22 0.0
2025-06-20 2025-06-21 0.0
2025-06-19 2025-06-19 0.0
2025-06-18 2025-06-18 0.0
2025-06-17 2025-06-17 0.0
2025-06-16 2025-06-16 0.0
2025-06-15 2025-06-15 0.0
2025-06-14 2025-06-14 0.0
2025-06-12 2025-06-13 0.0
2025-06-11 2025-06-11 0.0
2025-06-10 2025-06-10 0.0
2025-06-06 2025-06-09 0.0
2025-06-05 2025-06-05 0.0
2025-06-04 2025-06-04 0.0
2025-06-02 2025-06-03 0.0
2025-06-01 2025-06-01 0.0
2025-05-30 2025-05-31 0.0
2025-05-29 2025-05-29 0.0
2025-05-28 2025-05-28 0.0
2025-05-24 2025-05-27 0.0
2025-05-20 2025-05-23 0.0
2025-05-19 2025-05-19 0.0
2025-05-17 2025-05-18 0.0
2025-05-13 2025-05-16 0.0
2025-05-12 2025-05-12 0.0
2025-05-08 2025-05-11 0.0
2025-05-07 2025-05-07 0.0
2025-05-06 2025-05-06 0.0
2025-05-05 2025-05-05 0.0
2025-05-03 2025-05-04 0.0
2025-05-01 2025-05-02 0.0
2025-04-30 2025-04-30 0.0
2025-04-28 2025-04-29 0.0
2025-04-27 2025-04-27 0.0
2025-04-25 2025-04-26 0.0
2025-04-24 2025-04-24 0.0
2025-04-22 2025-04-23 0.0
2025-04-20 2025-04-21 0.0
2025-04-18 2025-04-19 0.0
2025-04-17 2025-04-17 0.0
2025-04-16 2025-04-16 0.0
2025-04-14 2025-04-15 0.0
2025-04-11 2025-04-13 0.0
2025-04-10 2025-04-10 0.0
2025-04-09 2025-04-09 0.0
2025-04-08 2025-04-08 0.0
2025-04-07 2025-04-07 0.0
2025-04-06 2025-04-06 0.0
2025-04-04 2025-04-05 0.0
2025-04-03 2025-04-03 0.0
2025-04-02 2025-04-02 0.0
2025-03-31 2025-04-01 0.0
2025-03-30 2025-03-30 0.0
2025-03-27 2025-03-29 0.0
2025-03-26 2025-03-26 0.0
2025-03-24 2025-03-25 0.0
2025-03-22 2025-03-23 0.0
2025-03-20 2025-03-21 0.0
2025-03-19 2025-03-19 0.0
2025-03-17 2025-03-18 0.0
2025-03-16 2025-03-16 0.0
2025-03-15 2025-03-15 0.0
2025-03-12 2025-03-14 0.0
2025-03-11 2025-03-11 0.0
2025-03-10 2025-03-10 0.0
2025-03-09 2025-03-09 0.0
2025-03-07 2025-03-08 0.0
2025-03-06 2025-03-06 0.0
2025-03-05 2025-03-05 0.0
2025-03-04 2025-03-04 0.0
2025-03-03 2025-03-03 0.0
2025-03-02 2025-03-02 0.0
2025-03-01 2025-03-01 0.0
2025-02-27 2025-02-28 0.0
2025-02-26 2025-02-26 0.0
2025-02-25 2025-02-25 0.0
2025-02-24 2025-02-24 0.0
2025-02-23 2025-02-23 0.0
2025-02-21 2025-02-22 0.0
2025-02-20 2025-02-20 0.0
2025-02-19 2025-02-19 0.0
2025-02-18 2025-02-18 0.0
2025-02-17 2025-02-17 0.0
2025-02-16 2025-02-16 0.0
2025-02-14 2025-02-15 0.0
2025-02-13 2025-02-13 0.0
2025-02-10 2025-02-12 0.0
2025-02-09 2025-02-09 0.0
2025-02-07 2025-02-08 0.0
2025-02-06 2025-02-06 0.0
2025-02-05 2025-02-05 0.0
2025-02-04 2025-02-04 0.0
2025-02-03 2025-02-03 0.0
2025-02-02 2025-02-02 0.0
2025-02-01 2025-02-01 0.0
2025-01-30 2025-01-31 0.0
2025-01-29 2025-01-29 0.0
2025-01-28 2025-01-28 0.0
2025-01-27 2025-01-27 0.0
2025-01-26 2025-01-26 0.0
2025-01-24 2025-01-25 0.0
2025-01-23 2025-01-23 0.0
2025-01-22 2025-01-22 0.0
2025-01-15 2025-01-21 0.0
2025-01-14 2025-01-14 0.0
2025-01-13 2025-01-13 0.0
2025-01-12 2025-01-12 0.0
2025-01-10 2025-01-11 0.0
2025-01-09 2025-01-09 0.0
2025-01-01 2025-01-08 20.4
2024-12-30 2024-12-31 20.4
2024-12-29 2024-12-29 20.4
2024-12-28 2024-12-28 20.4
2024-12-27 2024-12-27 0.0
2024-12-26 2024-12-26 0.0
2024-12-25 2024-12-25 0.0
2024-12-24 2024-12-24 0.0
2024-12-23 2024-12-23 0.0
2024-12-22 2024-12-22 0.0
2024-12-20 2024-12-21 0.0
2024-12-19 2024-12-19 0.0
2024-12-18 2024-12-18 0.0
2024-12-17 2024-12-17 0.0
2024-12-16 2024-12-16 0.0
2024-12-15 2024-12-15 0.0
2024-12-13 2024-12-14 0.0
2024-12-12 2024-12-12 0.0
2024-12-11 2024-12-11 0.0
2024-12-10 2024-12-10 0.0
2024-12-08 2024-12-09 0.0
2024-12-06 2024-12-07 0.0
2024-12-05 2024-12-05 0.0
2024-12-04 2024-12-04 0.0
2024-12-03 2024-12-03 0.0
2024-11-29 2024-12-02 0.0
2024-11-28 2024-11-28 0.0
2024-11-27 2024-11-27 0.0
2024-11-26 2024-11-26 0.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Principalmed 1L, UAB (code 135926717) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €555.8K, up 4.6% year on year, and returned to profitability with net profit of €73.1K after a loss of €5.0K in 2024. Profit before tax reached €91.2K, and the net profit margin improved to 13.1%. The revenue trend over the past three years shows a decline from €738.2K in 2023 to €531.3K in 2024, followed by a moderate recovery in 2025, though still below the 2023 level. The balance sheet strengthened materially in 2025: total assets increased to €412.0K, equity rose to €223.6K, and liabilities fell to €188.9K. Equity accounted for 54.3% of assets, with a debt-to-equity ratio of 0.84. Return on equity was 32.7% and return on assets 17.7%, supported by asset turnover of 1.35x. Revenue per employee was €111.2K, with profit per employee of €14.6K.